Filing Details

Accession Number:
0001209191-20-046666
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-13 18:54:15
Reporting Period:
2020-08-11
Accepted Time:
2020-08-13 18:54:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
860730 Hca Healthcare Inc. HCA Services-General Medical & Surgical Hospitals, Nec (8062) 273865930
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216843 Jr Bruce A Moore One Park Plaza
Nashville TN 37203
Group President - Service Line No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-02-06 14,648 $0.00 29,296 No 5 G Indirect By 2017 GRAT
Common Stock Acquisiton 2020-02-06 14,648 $0.00 40,552 No 5 G Indirect By MAM Trust (Spouse, Trustee)
Common Stock Disposition 2020-02-06 14,648 $0.00 14,648 No 5 G Indirect By 2017 GRAT
Common Stock Acquisiton 2020-02-06 14,648 $0.00 44,498 No 5 G Indirect By MRM Trust (Spouse, Trustee)
Common Stock Disposition 2020-02-06 14,648 $0.00 0 No 5 G Indirect By 2017 GRAT
Common Stock Acquisiton 2020-02-06 14,648 $0.00 40,552 No 5 G Indirect By TCM Trust (Spouse, Trustee)
Common Stock Disposition 2020-08-11 15,000 $133.73 88,626 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Indirect By 2017 GRAT
No 5 G Indirect By MAM Trust (Spouse, Trustee)
No 5 G Indirect By 2017 GRAT
No 5 G Indirect By MRM Trust (Spouse, Trustee)
No 5 G Indirect By 2017 GRAT
No 5 G Indirect By TCM Trust (Spouse, Trustee)
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 51,096 Indirect By 2018 GRAT
Common Stock 100,000 Indirect By 2020 GRAT
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.60 to $133.89, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.